M
MI:RNA Diagnostics
Veterinary diagnostic testing using microRNA biomarkers and AI
About MI:RNA Diagnostics
MI:RNA Diagnostics is a veterinary diagnostics company that develops testing technology for early-stage disease in animals. Founded in 2019 by Dr. Eve Hanks as a spin-out from Scotland's Rural College, the company is headquartered in Edinburgh, Scotland. Dr. Hanks, a veterinary surgeon with a PhD in immunology, identified the potential to combine microRNA (miRNA) biomarkers with artificial intelligence to create a new diagnostic platform. This led to the creation of the company, with Dr. Hanks as CEO and later joined by co-founder Dr. Robert Coultous, who serves as CSO.
Read full description
The company’s core technology analyzes blood samples for specific microRNA biomarkers to detect diseases before clinical symptoms appear. This platform is applicable across companion animals, agriculture, and equine sectors. MI:RNA's initial products include a cardiac health screening test for early-stage heart disease in cats and dogs and a test for Johne's disease in cattle. The business model is centered on providing these advanced diagnostic tests to veterinary practices, allowing vets to offer enhanced preventative care and improve patient outcomes. The company collaborates with industry partners and distributors to bring its technology to a broader market.
MI:RNA Diagnostics has secured multiple rounds of funding, including a $4 million Series A round in July 2024. Investors include NovaQuest Capital Management, Animal Health Angels, Equity Gap, and Scottish Enterprise, reflecting international confidence in the company's growth potential. The firm has also received numerous awards and grants for its work.
At a glance
- Status
- Operational
- Founded
- 2019
- Headquarters
- Whitburn, United Kingdom
- Employees
- 29
- Open positions
- None listed
- Dealroom signal
- 78.4/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotech & Life Sciences, Veterinary, Biotechnology, Precision Medicine, Spinout, Pets, Woman Founder, Seal of Excellence EC, DT and LS
- Technology
- Artificial Intelligence
- Business model
- Manufacturing
- Client focus
- b2c
Latest news
Press, funding announcements and product moves mentioning MI:RNA Diagnostics.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Dec 2025 | $3.6M | $20M | NovaQuest Capital Management · Gabriel Investment Syndicate · Veterinary Angel Network For Entrepreneurs · Equity Gap | ↗ |
| SERIES A✓Equity / VC | Jul 2024 | $4M | $16M | Scottish Enterprise Growth Investments · Equity Gap · Gabriel Investment Syndicate · Kyoritsu Seiyaku | ↗ |
Growth signals
Latest recorded traffic for MI:RNA Diagnostics is 860 monthly website visits, up 0% over the last three months. MI:RNA Diagnostics's team grew 11.5% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Leap Venture Studio
Series A10 investors entered at this stage
NovaQuest Capital Management
Scottish Enterprise Growth Investments
Equity Gap
Gabriel Investment Syndicate
Kyoritsu Seiyaku
Veterinary Angel Network For Entrepreneurs
Animal Health Angels
Digitalis Ventures
AniVC
Holstein UK
Other known investors4 additional known investors
SRUC
R/GA Ventures
Scottish EDGE
Techscaler
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about MI:RNA Diagnostics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See MI:RNA Diagnostics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.